Antigenicity and immunogenicity of collagen

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 71, Issue 2, 2004, Pages 343-354

  Lynn, A K ^a   Yannas, I V ^b   Bonfield, W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Antigenicity; Atelocollagen; Clinical response; Collagen; Collagen induced autoimmunity; Crosslinking; Immunogenicity; Pepsin treatment

Indexed keywords

COLLAGEN; IMMUNOLOGY;

ANTIGENICITY; BIOMEDICAL DEVICES; IMMUNOCHEMISTRY; IMMUNOGENICITY;

ANTIGENS;

ANTIBODY; ANTIGEN; ATELOCOLLAGEN; BIOMATERIAL; COLLAGEN; COLLAGEN TYPE 1; IMMUNOGLOBULIN G;

ANTIGEN ANTIBODY REACTION; ANTIGENICITY; AUTOIMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; MACROMOLECULE; MEDICAL INSTRUMENTATION; NONHUMAN; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS; BIOCOMPATIBLE MATERIALS; COLLAGEN; CROSS-LINKING REAGENTS; EQUIPMENT AND SUPPLIES; HUMANS;

EID: 7744230281     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30096     Document Type: Review

References (121)

1. Li ST. Biologic biomaterials: Tissue-derived biomaterials (Collagen). In: Brozino JD, editor. The biomedical engineering handbook. Boca Raton, FL: CRC Press; 1995. p 627-647.
2. Gorham SD. Collagen. In: Byrom D, editor. Biomaterials. New York: Stockton Press; 1991. p 55-122.
3. Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons. Aust N Z J Opthalmol 1996;24:257-260.
4. Rapaport M. Granuloma annulare caused by injectable collagen. Arch Dermatol 1984;120:837-838.
5. Webster RC, Kattner MD, Smith RC. Injectable collagen for augmentation of facial areas. Arch Otolaryngol 1984;110:652-656.
6. Baumann LS, Kerdel F. The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg 1999;25:247-249.
7. Ellingsworth LR, DeLustro F, Brennan JE, Sawamura S, McPherson J. The human immune response to reconstituted bovine collagen. J Immunol 1986;136:877-882.
8. McGregor DH, MacArthur RI, Carter T. Avitene granulomas of colonic serosa. Ann Clin Lab Sci 1986;16:296-302.
9. Bauer TW, Muschler GF. Bone graft materials - An Overview of the basic science. Clin Orthop 2000;371:10-27.
10. Block JE, Poser J. Does xenogeneic demineralized bone-matrix have clinical utility as a bone-graft substitute. Med Hypotheses 1995;45:27-32.
11. Park SZ, Reardon MJ. Current status of stentless aortic xenografts. Curr Opin Cardiol 2000;15:74-81.
12. Reardon MJ, David TE. Stentless xenograft aortic valves. Curr Opin Cardiol 1999;14:84-89.
13. Yannas IV. Collagen and gelatin in the solid state. J Macromol Sci Rev Macromol Chem 1972;C7:49-104.
14. Friess W. Collagen - Biomaterial for drug delivery. Eur J Pharmaceut Biopharmaceut 1998;45:113-136.
15. Furthmayr F, Timpl R. Immunochemistry of collagens and procollagens. Int Rev Connect Tissue Res 1976;7:61-99.
16. Timpl R. Immunological studies on collagen. In: Ramachandran GN, Reddi AH, editors. Biochemistry of collagen. New York: Plenum Press; 1976.
17. DeLustro F, Condell RA, Nguyen MA, McPherson JM. A comparative-study of the biologic and immunological response to medical devices derived from dental collagen. J Biomed Mater Res 1986;20:109-120.
18. Allaire E, Guettier C, Bruneval P, Plissonnier D, Michel JB. Cell-free arterial grafts: Morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 1994;19:446-456.
19. Esses SI, Halloran PF. Donor marrow-derived cells as immunogens and targets for the immune-response to bone and skin allografts. Transplantation 1983;35:169-174.
20. Dahm M, Lyman WD, Schwell AB, Factor SM, Frater RW. Immunogenicity of glutaraldehyde-tanned bovine pericardium. J Thorac Cardiovasc Surg 1990;99:1082-1090.
21. Jayakrishnan A, Jameela SR. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. Biomaterials 1996;17:471-484.
22. Speer DP, Chvapil M, Eskelson CD, Ulreich J. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. J Biomed Mater Res 1980;14:753-764.
23. Crumpton MJ. Protein antigens: The molecular basis of antigenicity and immunogenicity. In: Sela M, editor. The antigens. New York: Academic Press; 1974. p 1-78.
24. Spira M, Liu BC, Xu ZL, Harrell R, Chahadeh H. Human amnion collagen for soft-tissue augmentation - Biochemical characterizations and animal observations. J Biomed Mater Res 1994;28:91-96.
25. Liu B, Harrell R, Xu ZL, Dresden MH, Spilker M. Immune response to gamma-irradiated injectable human amnion and human skin collagens in the rat. Arch Dermatol 1989;125:1084-1089.
26. Fietzek PP, Kuhn K. The primary structure of collagen. Int Rev Connect Tissue Res 1976;7:1-60.
27. Furthmayr F, Beil W, Timpl R. Different antigenic determinants in the polypeptide chains of human collagen. FEBS Lett 1971;12:341-344.
28. Davison PF, Levine L, Drake MP, Rubin A, Bump S. The serologic specificity of tropocollagen telopeptides. J Exp Med 1967;126:331-349.
29. Michaeli D, Martin GR, Kettman J, Benjamin E, Leung DYK, Blatt BA. Localization of antigenic determinants in the polypeptide chains of collagen. Science 1969;166:1522-1524.
30. Pontz B, Meigel W, Rauterberg J, Kuhn K. Localization of two species specific antigenic determinants on the peptide chains of calf skin collagen. Eur J Biochem 1970;16:50-54.
31. Beil W, Timpl R, Furthmayr F. Conformation dependence of antigenic determinants on the collagen molecule. Immunology 1973;24:13-24.
32. Furthmayr F, Stoltz M, Becker U, Beil W, Timpl R. Chicken antibodies to soluble rat collagen. II. Specificity of the reactions with individual polypeptide chains and cyanogen bromide peptides of collagen. Immunochemistry 1972;9:789-798.
33. Nowack H, Hahn E, Timpl R. Specificity of the antibody response in inbred mice to bovine type I and type II collagen. Immunology 1975;29:621-628.
34. Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type-II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular-cartilage cultured with interleukin-1. J Clin Invest 1989;83:647-661.
35. Hahn E, Timpl R. Involvement of more than a single polypeptide chain in the helical antigenic determinants of collagen. Eur J Immunol 1973;3:442-446.
36. Hahn E, Timpl R, Miller EJ. The production of specific antibodies to native collagens with the chain compositions, (alpha1(I))3, (alpha1(II))3, and (alpha1(I))2alpha2. J Immunol 1974;113:421-423.
37. Iwasa J, Ochi M, Uchio Y, Katsube K, Adachi N, Kawasaki K. Effect of cell density on proliferation and matrix synthesis of condrocytes embedded in atelocollagen gel. Artif Organs 2003;27:249-255.
38. Sakai D, Mochida J, Yamamoto Y, Nomura T, Okuma M. Nishimura K, Nakai T, Ando K, Hotta T. Transplantation of mesenchymal stem cells embedded in atelocollagen((R)) gel to the intervertebral disc: A potential therapeutic model for disc degeneration. Biomaterials 2003;24:3531-3541.
39. Uchio Y, Ochi M, Matsusaki M, Kurioka H, Katsube K. Human chondrocyte proliferation and matrix synthesis cultured in atelocollagen (R) gel. J Biomed Mater Res 2000;50:138-143.
40. Luck EE, Daniels JR, inventors; Collagen Corporation, assignee. US4233360: Non-antigenic collagen and articles of manufacture. USA. 1980.
41. Nowack H, Hahn E, Timpl R. Requirement for T cells in the antibody response of mice to calf skin collagen. Immunology 1976;30:29-32.
42. Fuchs S, Mozes E, Maoz A, Sela M. Thymus independence of a collagen-like synthetic polypeptide and of collagen, and the need for thymus and bone marrow-cell cooperation in the immune response to gelatin. J Exp Med 1974;139:148-158.
43. Cooperman L, Michaeli D. The immunogenicity of injectable collagen. 1. A 1-year prospective-study. J Am Acad Dermatol 1984;10:638-646.
44. Cooperman L, Michaeli D. The immunogenicity of injectable collagen. 2. A retrospective review of 72 tested and treated patients. J Am Acad Dermatol 1984;10:647-651.
45. Charriere G, Bejot M, Schnitzler L, Ville G, Hartmann DJ. Reactions to a bovine collagen implant - Clinical and immunological study in 705 patients. J Am Acad Dermatol 1989;21:1203-1208.
46. Eaglstein WH, Alvarez OM Auletta M, Leffel D, Rogers GS, Zitelli JA, Norris JEC, Thomas I, Irondo M, Fewkes J, Hardin-Young J, Duff RG, Sabolinski ML. Acute excisional wounds treated with a tissue-engineered skin (apligraf). Dermatol Surg 1999;25:195-201.
47. Budinger L, Hertl M. Immunological mechanisms in hypersensitivity reactions to metal ions: An overview. Allergy 2000;55:108-115.
48. von Blomberg van der Flier M, van der Burg CK, Pos O. In vitro studies in nickel allergy: Diagnostic value of a dual parameter analysis. J Invest Dermatol 1987;88:362-368.
49. Meyer KK, Beezhold DH. Latex allergy: How safe are your gloves? Bull Am Coll Surg 1997;82:13-15.
50. Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol 1989;15:301-303.
51. Snyder CC. On the history of the suture. Plastic Reconstruct Surg 1976;58:401-406.
52. Carroll RE. Surgical catgut: The myth of allergy. J Hand Surg [Br] 1989;14B:218-220.
53. Tripp HD. Catgut allergy (case report). J Ind State M Assoc 1935;28:383-384.
54. Getzen LC, Jansen GA. Correlation between allergy to suture material and postoperative wound infections. Surgery 1966;60:824-826.
55. Sykes B. The molecular genetics of collagen. Bioessays 1985;3:112-117.
56. Lemperle G, Hazangauthier N, Lemperle M. PMMA microspheres (artecoll) for skin and soft-tissue augmentation. 2. Clinical investigations. Plastic Reconstruct Surg 1995;96:627-634.
57. Millikan L. Long-term safety and efficacy with fibrel in the treatment of cutaneous scars - Results of a multicenter study. J Dermatol Surg Oncol 1989;15:837-842.
58. Burkus JK, Heim SE, Gornet MF, Zdeblick TA. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Technol 2003;16:113-122.
59. Muschler GF, Negami S, Hyodo A, Gaisser D, Easley K, Kambic H. Evaluation of collagen ceramic composite graft materials in a spinal fusion model. Clin Orthop1996;328:250-260.
60. Cornell CN, Lane JM, Chapman M, Merkow R, Seligson D, Henry S, Gustillo R, Vincent K. Multicenter trial of collagraft as bone graft substitute. J Orthopaed Trauma 1991;5:1-8.
61. Chapman MW, Bucholz R, Cornell C. Treatment of acute fractures with a collagen-calcium phosphate graft material - A randomized clinical trial. J Bone Joint Surg [Am] 1997;79A: 495-502.
62. Mehlisch DR. Collagen/hydroxylapatite implant for augmenting deficient alveolar ridges: A 24-month clinical and histologic summary. Oral Surg Oral Med Oral Pathol 1989;68:505-514.
63. Mehlisch DR, Taylor TD, Leibold DG, Hiatt R, Waite DE, Waite PD, Laskin DM, Smith ST. Collagen/hydroxylapatite implant for augmentating deficient alveolar ridges. J Oral Maxillofac Surg 1988;44:839-843.
64. Hemmerle J, Leize M, Voegel JC. Long-term behavior of a hydroxyapatite collagen-glycosaminoglycan biomaterial used for oral-surgery - A case-report. J Mater Sci Mater Med 1995;6:360-366.
65. Yannas IV, Burke JF, Orgill DP, Skrabut EM. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science 1982;215:174-176.
66. Burke JF, Yannas IV, Quinby WC, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981;194:413-428.
67. Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci USA 1989;86:933-937.
68. Purdue GF, Hunt JL, Gillespie RW, Hansbrough JF, Dominic WJ, Robson MC, Smith DJ, Macmillan BG, Waymac JP, Herndon DN, Desai M, Terry BE, Bendlin A, Declement FA, Kahn AM, Hanumadass ML, Matsuda T. Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. J Trauma Injury Infect Crit Care 1987;27:155-157.
69. Tavis MJ, Thornton JW, Harriett RH, Roth JC, Woodroof EA. A new composite skin prosthesis. Burns 1980;7:123-130.
70. Boyce S, inventor The regents of the University of California, assignee. US5273900: Method and apparatus for preparing composite skin replacement. USA. 1993.
71. Eaglstein WH, Falanga V. Tissue engineering and the development of apligraf(R), a human skin equivalent. Clin Ther 1997;19:894-905.
72. Nelson PA, Powers JN, Estridge TD, Elder EA, Alea AD, Sidhu PK, Sehl LC, DeLustro FA. Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma. J Biomed Mater Res 2001;58:710-719.
73. Tsuda H, Higashi S, Iwanaga S, Kubota T, Morita T, Yanaga K. Development of antitissue factor antibodies in patients after liver surgery. Blood 1993;82:96-102.
74. Browder IW, Litwin MS. Use of absorbable collagen for hemostasis in general surgical patients. Am Surg 1986;52:492-494.
75. Sakon M, Monden M, Gotoh M, Kobayashi K, Kambayashi J, Mori T, Okamura J. Use of microcrystalline collagen powder and fibrinogen tissue adhesive for hemostasis and prevention of rebleeding in patients with hepatocellular- carcinoma associated with cirrhosis of the liver. Surg Gynecol Obstet 1989;168:453-454.
76. Alexander J, Rabinowitz J. Microfibrillar collagen (Avitene) as a hemostatic agent in experimental oral wounds. J Oral Surg 1978;36:202-205.
77. Kaplan EN. Clinical variations in the utilization of zyderm-I and zyderm-Ii. Plastic Reconstuct Surg 1984;73:329.
78. Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J, Jordan M, McManus W, Solem L, Warden G, Zawacki B. Artificial dermis for major burns - A multi-center randomized clinical-trial. Ann Surg 1988;208:313-320.
79. Michaeli D, MacPherson M. Immunologic study of artificial skin used in the treatment of thermal injuries. Burn Care Rehab 1990;11:21-26.
80. Yannas IV, Burke JF. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 1980;14:65-81.
81. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 1980;14:107-132.
82. Walsh WR, Harrison J, Loefler A, Martin T, Van Sickle D, Brown MK, Sonnabend DH. Mechanical and histologic evaluation of collagraft in an ovine lumbar fusion model. Clin Orthop 2000;375:258-266.
83. Hagiwara A, Nakashima S, Itoh T, Sakakura C, Otsuji E, Yamagishi H, Okajima S, Kusuzaki K, Hase H, Kubo S, Soh J, Miki T, Toba T, Nakamura T, Shimizu, Y. Clinical application of PGA-tube for regeneration of intrapelvic nerves during extended surgery for intrapelvic recurrent rectal cancer. Gan To Kagaku Ryoho 2002;29:2202-2204.
84. Nakamura T. Clinical application of nerve conduits consisting of a polyglycolic acid (PGA)-collagen composite tube filled with collagen sponge. Connect Tissue 2003;35:53-57.
85. Onodera J, Saito A, George J, Iwasaki T, Ito H, Aso Y, Hamano T. Kanai A, Miyata T, Nagai Y. Application of atelocollagen solution for lacrimal duct occlusion. In: Lacrimal gland, tear film, and dry eye syndromes 3: Basic science and clinical relevance, parts A and B. Norwell, MA: Kluwer Academic; 2002. p. 1277-1281.
86. Kohmura E, Yuguchi T, Yoshimine T, Fujinaka T, Koseki N, Sano A, Kishino A, Nakayama C, Sakaki T, Nonaka M, Takemoto O, Hayakawa T. BDNF atelocollagen mini-pellet accelerates facial nerve regeneration. Brain Res 1999;849:235-238.
87. Vizarova K, Bakos D, Rehakova M, Macho V. Modification of layered atelocollagen by ultraviolet-irradiation and chemical cross-linking-structure stability and mechanical-properties. Biomaterials 1994;15:1082-1086.
88. Yamamoto S, Yoshimine T, Fujita T, Kuroda R, Irie T, Fujioka K, Hayakawa T. Protective effect of Ngf atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbils. Neurosci Lett 1992;141:161-165.
89. Schmitt FO, Lenvine L, Drake MP, Rubin AL, Pfahl O, Davison PF. The antigenicity of tropocollagen. Proc Natl Acad Sci USA 1964;51:493-497.
90. Kadler KE, Holmes DF, Trotter JA, Chapman JA. Collagen fibril formation. Biochem J 1996;316:1-11.
91. Kikuchi M, Itoh S, Ichinose S, Shinomiya K, Tanaka J. Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials 2001;22:1705-1711.
92. Liu B, Harrell R, Davis RH, Dresden MH, Spira M. The Effect of gamma irradiation on injectable human amnion collagen. J Biomed Mater Res 1989;23:833-844.
93. Weadock KS, Miller EJ, Bellincampi LD, Zawadsky JP, Dunn MG. Physical crosslinking of collagen fibers: Comparison of ultraviolet irradiation and dehydrothermal treatment. J Biomed Mater Res 1995;29):1373-1379.
94. Weadock KS, Miller EJ, Keuffel EL, Dunn MG. Effect of physical crosslinking methods on collagen-fiber durability in proteolytic solutions. J Biomed Mater Res 1996;32:221-226.
95. Toba T, Nakamura T, Lynn AK, Matsumoto K, Fukuda S, Yoshitani M, Hori Y, Shimizu Y. Evaluation of peripheral nerve regeneration across an 80-mm gap using a polyglycolic acid (PGA) - Collagen nerve conduit filled with laminin-soaked collagen sponge in dogs. Int J Artif Organs 2002;25: 230-237.
96. Grabarek Z, Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990;185:131-135.
97. Girton TS, Oegema TR, Tranquille RT. Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering. J Biomed Mater Res 1999;46:87-92.
98. Kikuchi M, Taguchi T, Matsumoto HN, Takakuda K, Tanaka J. Cross-linkage of hydroxyapatite/collagen nano-composite with 3 different reagents. Bioceramics 2002;14:449-452.
99. Khor E. Methods for the treatment of collagenous tissues for bioprostheses. Biomaterials 1997;18:95-105.
100. Ohan MP, Weadock KS, Dunn MG. Synergistic effects of glucose and ultraviolet irradiation on the physical properties of collagen. J Biomed Mater Res 2002;60:384-391.
101. Huang-Lee LL, Cheung DT, Nimm ME. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks. J Biomed Mater Res 1990;24:1185-1201.
102. van Luyn MJ, van Wachem PB, Olde Damink LH, Dijkstra PJ, Feijen J, Nieuwenhuis P. Secondary Cytotoxicity of cross-linked dermal sheep collagens during repeated exposure to human fibroblasts. Biomaterials 1992;13:1017-1024.
103. Yao CH, Sun JS, Lin FH, Liao CJ, Huang CW. Biological Effects and cytotoxicity of tricalcium phosphate and formaldehyde cross-linked gelatin composite. Mater Chem Phys 1996;45:6-14.
104. Courtman DW, Errett BF, Wilson GJ. The Role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J Biomed Mater Res 2001;55:576-586.
105. DeLustro F, Dasch J, Keefe J, Ellingsworth L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop 1990;260:263-279.
106. Cohen LH, Koster JK, Mee RB, Collins JJJ. Long-term follow-up of the Hancock bioprosthetic heart valve: A 6-year review. Circulation 1979;60:87-92.
107. Lu JX, Gallur A, Flautre B, Anselme K, Descamps M, Thierry B, Hardouin P. Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. J Biomed Mater Res 1998;42:357-367.
108. Schwacha MG, Chaudry IH. The cellular basis of post-bum immunosuppression: Macrophages and mediators (review). Int J Mol Med 2002;10:239-243.
109. Trentham DE, Townes AS, Kang AH. Autoimmunity to Type II collagen: An experimental model of arthritis. J Exp Med 1977;146:857-868.
110. Yoo TJ, Stuart JM, Takeda T, Sudo N, Floyd RA, Ishibe T, Olson G, Orchik D, Shea JJ, Kang AH. Induction of type-1: I. Collagen autoimmune arthritis and ear disease in monkey. Ann N Y Acad Sci 1986;475:341-342.
111. Cathcart ES, Hayes KC, Gonnerman WA, Lazzari AA, Franzblau C. Experimental arthritis in a nonhuman primate:1. Induction by bovine type-II collagen. Lab Invest 1986;54:26-31.
112. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-668.
113. Svensson L, Jirholt J, Holmdahl R, Jansson L. B Cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998;111:521-526.
114. Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM. Induction of arthritis with monoclonal-antibodies to collagen. J Immunol 1992;148:2103-2108.
115. Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis - Correlation with disease progression. Arthritis Rheum 1996;39:1720-1727.
116. Ronnelid J, Lysholm J, Engstromlaurent A, Klareskog L, Heyman B. Local anti-type-II collagen antibody-production in rheumatoid-arthritis synovial-fluid - Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum 1994;37:1023-1029.
117. Morgan K, Clague RB, Collins I, Ayad S, Phinn SD, Holt PJL. A longitudinal-study of anticollagen antibodies in patients with rheumatoid-arthritis. Arthritis Rheum 1989;32:139-145.
118. Cremer MA, Rosloniec EF, Kang AH. The cartilage collagens: A Review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 1998;76:275-288.
119. Luross JA, Williams NA. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 2001;103:407-416.
120. Mainil-Varlet P, Rieser F, Grogan S, Mueller W, Saager C, Jakob RP. Articular cartilage repair using a tissue-engineered cartilage-like implant: An animal study. Osteoarthritis Cartilage 2001;9:S6-S15.
121. Nehrer S, Breinan HA, Ramappa A, Hsu HP, Minas T, Shortkroff S, Sledge CB, Yannas IV, Spector M. Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials 1998;19:2313-2328.